Advantage Powder
97/100
This product looks safe
- Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
- 33% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
Label Data
3 Gram(s)
Serving Size
100
Servings
Other Combinations
Product Type
33%
Evidence Coverage
Supplement Facts — Evidence Check
Calories
9 {Calories}
Total Fat
1 g
(2% DV)
50 mg
(250% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 1.4× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
50 mg
(2500% DV)
📊 38.5× RDA — above typical dose (UL: 100 mg)
📚 113 studies (Tier A: 3, B: 35)
Lecithin
2000 mg
Polysaccharides
1500 mg
Mucopolysaccharides
500 mg
EDTA
300 mg
250 mg
✅ Within RDA (0.5× RDA of 550 mg)
📚 36 studies (Tier A: 1, B: 7)
Papain
250 mg
Cellulose
100 mg
50 mg
📊 Market median: 108.0mg (8 products)
📚 9 studies (Tier A: 0, B: 4)
Label Claims — Verification
❓
All Other
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Dairy Free
Sugar Free
Product Information
📋 Directions for Use
Suggested Usage: As a dietary supplement, adults take 1 teaspoon twice daily or as directed by your healthcare professional.
⚠️ Warnings & Precautions
KEEP OUT OF REACH OF CHILDREN.
Tamper resistant package, do not use if outer seal is missing.
🧪 Formulation Notes
This product contains NO yeast, milk/dairy, corn, sodium, sugar, starch, artificial coloring, preservatives or flavoring.
Additional Information
For optimal storage conditions, store in a cool, dry place. (59(0)-77(0)F/(15(0)-25(0)C) (35-65% relative humidity)
Formula #7474P
Product Details
UPC / SKU
3 10539 01807 1
DSLD Entry Date
2012-06-25
Product Type
Other Combinations
Form
Powder
Brand
Douglas Laboratories
DSLD ID
8771
Data Updated
2026-04-11
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
ENGN Pre-Workout Engine Fruit Punch
Evlution Nutrition
100
ENGN Pre-Workout Engine Watermelon
Evlution Nutrition
100
ENGN Pre-Workout Cherry Limeade
Evlution Nutrition
100
ENGN Pre-Workout Engine Furious Grape
Evlution Nutrition
100
ENGN Pre-Workout Pink Lemonade
Evlution Nutrition
100